- Presentations
- 3
- Markets
- 1
Relistor is a brand of Methylnaltrexone marketed by Salix Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Methylnaltrexone
- Brand owner
- Salix Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 12 mg/0.6 mL injection, 8 mg/0.4 mL injection, 150 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Relistor 12 mg/0.6 mL injectionSubcutaneous | Salix Pharmaceuticals | US FDA | Available on request |
| Relistor 8 mg/0.4 mL injectionSubcutaneous | Salix Pharmaceuticals | US FDA | Available on request |
| Relistor 150 mg tabletOral | Salix Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Relistor
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.